Premium
Linking medicine and economics: health economics and quality of life in haemophilia care
Author(s) -
Schramm W.,
Berger K.
Publication year - 2002
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1046/j.1365-2516.2002.00639.x
Subject(s) - haemophilia , medicine , health care , medical economics , quality (philosophy) , quality of life (healthcare) , face (sociological concept) , scarcity , health economics , quality adjusted life year , medline , cost effectiveness , risk analysis (engineering) , economics , economic growth , nursing , microeconomics , pediatrics , social science , political science , law , philosophy , epistemology , sociology
Summary. Scarce resources in healthcare are a fact of life everywhere. Providing optimal healthcare for haemophilia means delivering the best possible clinical outcomes at an acceptable total cost, however that is defined by individual societies. Health economics helps us to do this. So far, economic evaluation has enhanced our understanding of some of the economic implications of haemophilia and has provided some guidance on the way forward to optimize efficient allocation of resources for this condition. Further advances and consensus on evaluation methods and standards for the economics of haemophilia are required, however. This need will continue in the face of new, more sophisticated and therefore more costly haemophilia therapies.